Don Kotler 

AIDSmeds founder Peter Staley interviewed Dr. Donald Kotler, chief of gastroenterology at St. Luke’s-Roosevelt Hospital in New York, and a longtime researcher of wasting, lipodystrophy, and metabolic problems in people with HIV. Kotler discusses TH-9507, an experimental drug for reducing fat around the gut; Fosamax helping with bone loss in HIVers; high-fat diets in people with HIV; and whether lipid-lowering drugs work well for HIVers.

Double click for the full interview (21 minutes):


Or hear part I about TH-9507, an experimental drug for reducing fat around the gut (8 minutes):


Or hear part II about Fosamax helping with bone loss in HIVers (6 minutes):


Or hear part III about high-fat diets in people with HIV (2 minutes):


Or hear part IV about whether lipid-lowering drugs work well for HIVers (5 minutes):


Or click here to read the full transcript of the interview.